SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention
Open Access
- 4 March 2021
- journal article
- review article
- Published by MDPI AG in Microorganisms
- Vol. 9 (3), 525
- https://doi.org/10.3390/microorganisms9030525
Abstract
The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is a high-risk viral agent involved in the recent pandemic stated worldwide by the World Health Organization. The infection is correlated to a severe systemic and respiratory disease in many cases, which is clinically treated with a multi-drug pharmacological approach. The purpose of this investigation was to evaluate through a literature overview the effect of adjuvant therapies and supplements for the SARS-CoV-2 infection. The research has analyzed the advantage of the EK1C4, by also assessing the studies on the resveratrol, vitamin D, and melatonin as adjuvant supplements for long hauler patients’ prognosis. The evaluated substances reported important benefits for the improvement of the immune system and as a potential inhibitor molecules against SARS-CoV-2, highlighting the use of sartans as therapy. The adjuvant supplements seem to create an advantage for the healing of the long hauler patients affected by chronic symptoms of constant chest and heart pain, intestinal disorders, headache, difficulty concentrating, memory loss, and tachycardia.Keywords
This publication has 240 references indexed in Scilit:
- Novel resveratrol nanodelivery systems based on lipid nanoparticles to enhance its oral bioavailabilityInternational Journal of Nanomedicine, 2013
- Platelet Rich Fibrin (P.R.F.) in Reconstructive Surgery of Atrophied Maxillary Bones: Clinical and Histological EvaluationsInternational Journal of Medical Sciences, 2012
- Epithelial Cells Lining Salivary Gland Ducts Are Early Target Cells of Severe Acute Respiratory Syndrome Coronavirus Infection in the Upper Respiratory Tracts of Rhesus MacaquesJournal of Virology, 2011
- Saliva: diagnostics and therapeutic perspectivesOral Diseases, 2010
- Differential Downregulation of ACE2 by the Spike Proteins of Severe Acute Respiratory Syndrome Coronavirus and Human Coronavirus NL63Journal of Virology, 2010
- Role of Spike Protein Endodomains in Regulating Coronavirus EntryOnline Journal of Public Health Informatics, 2009
- Characterization of a Highly Conserved Domain within the Severe Acute Respiratory Syndrome Coronavirus Spike Protein S2 Domain with Characteristics of a Viral Fusion PeptideJournal of Virology, 2009
- Polyphenols, oral health and disease: A reviewJournal of Dentistry, 2009
- Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cellsGenes & Nutrition, 2007
- The role of melatonin in immuno‐enhancement: potential application in cancerInternational Journal of Experimental Pathology, 2006